Published in Eur J Immunol on December 01, 2000
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood (2008) 3.05
Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med (2003) 2.30
Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J (2003) 1.69
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest (2008) 1.27
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy. Br J Pharmacol (2002) 0.92
Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation: evidence that WIP-WASP dissociation is not required and that the WIP NH2 terminus is inhibitory. J Biol Chem (2007) 0.88
The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression. Adv Pharmacol (2013) 0.87
Antigen dose, type of antigen-presenting cell and time of differentiation contribute to the T helper 1/T helper 2 polarization of naive T cells. Immunology (2003) 0.87
PKCθ regulates T cell motility via ezrin-radixin-moesin localization to the uropod. PLoS One (2013) 0.86
Intervention of PKC-θ as an immunosuppressive regimen. Front Immunol (2012) 0.82
The role of the e3 ligase cbl-B in murine dendritic cells. PLoS One (2013) 0.79
Widespread expression of PICOT in mouse and human tissues with predominant localization to epithelium. J Histochem Cytochem (2010) 0.77
The Role of PKC-θ in CD4+ T Cells and HIV Infection: To the Nucleus and Back Again. Front Immunol (2015) 0.75
Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science (2001) 4.29
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation (1999) 3.08
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature (1977) 3.04
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet (1996) 2.47
Studies on the amphipathic nature of the membrane proteins in Semliki Forest virus. J Mol Biol (1974) 2.37
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest (1987) 2.35
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J Clin Invest (2001) 2.29
mtDNA analysis of Nile River Valley populations: A genetic corridor or a barrier to migration? Am J Hum Genet (1999) 2.25
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity (1995) 2.19
Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem (2001) 2.16
Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet (1979) 2.14
Lipoprotein(a): resurrected by genetics. J Intern Med (2012) 2.12
Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science (1993) 2.10
Noxa: at the tip of the balance between life and death. Oncogene (2008) 2.09
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res (1982) 2.01
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci U S A (1999) 1.99
Visualization of the conservation of synteny between humans and pigs by heterologous chromosomal painting. Genomics (1995) 1.94
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92
The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet (1991) 1.88
Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett (1975) 1.87
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ (2007) 1.84
Apolipoprotein E polymorphism in health and disease. Am Heart J (1987) 1.84
In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ (2008) 1.81
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J Biol Chem (2000) 1.76
Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy? Cell Death Differ (2008) 1.73
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ (2006) 1.72
Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet (1988) 1.68
Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet (1979) 1.66
Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev (1999) 1.64
The enigma of caspase-2: the laymen's view. Cell Death Differ (2008) 1.63
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene (1999) 1.60
Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet (1991) 1.59
The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia (2007) 1.56
Lipoprotein(a) in renal disease. Am J Kidney Dis (1996) 1.51
Expression of p53 during mouse embryogenesis. Development (1991) 1.50
Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol Today (2000) 1.50
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Switching from simple to complex oscillations in calcium signaling. Biophys J (2000) 1.48
Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol (1999) 1.46
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status. Br J Haematol (1997) 1.46
A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution? Trends Genet (2001) 1.46
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia (1993) 1.42
Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. Hoppe Seylers Z Physiol Chem (1975) 1.39
Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer (2000) 1.39
Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun (1993) 1.37
Bim and Bmf in tissue homeostasis and malignant disease. Oncogene (2008) 1.36
A role for the beta isoform of protein kinase C in fear conditioning. J Neurosci (2000) 1.36
Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet (1989) 1.34
Expression, phosphorylation and nuclear localization of the human P1 protein, a homologue of the yeast Mcm 3 replication protein. J Cell Sci (1995) 1.34
The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer (1998) 1.33
Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Biochem J (2000) 1.32
Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett (1983) 1.32
Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. J Biol Chem (2001) 1.32
Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol (1994) 1.27
Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem (1985) 1.27
PACSIN, a brain protein that is upregulated upon differentiation into neuronal cells. Eur J Biochem (1998) 1.26
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet (1992) 1.26
Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet (1984) 1.26
Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem (1983) 1.26
In situ hybridization studies on variant t(2;8) translocations in Burkitt lymphoma lines. Hum Genet (1986) 1.25
Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science (1989) 1.24
Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int (2006) 1.23
Assignment of the gene for human glucose dehydrogenase (E.C. 1.1.1.47) to chromosome 1 using somatic cell hybrids. Cytogenet Cell Genet (1978) 1.22
Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway. Oncogene (2006) 1.21
Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol Cell Biol (1996) 1.20
Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol (1996) 1.20
Partial monosomy 22pter leads to q11 in a newborn with the clinical features of trisomy 13 syndrome. Ann Genet (1980) 1.20
Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta. Blood (2000) 1.19
p56lck-independent activation and tyrosine phosphorylation of p72syk by T-cell antigen receptor/CD3 stimulation. Proc Natl Acad Sci U S A (1994) 1.19
An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem (1979) 1.18
Breakpoint analysis of the pericentric inversion between chimpanzee chromosome 10 and the homologous chromosome 12 in humans. Cytogenet Genome Res (2005) 1.18
An X-chromosome linked locus contributes to abnormal placental development in mouse interspecific hybrid. Nat Genet (1996) 1.18
Localization of the active type I DNA topoisomerase gene on human chromosome 20q11.2-13.1, and two pseudogenes on chromosomes 1q23-24 and 22q11.2-13.1. Hum Genet (1989) 1.17
Localization of the human bona fide calmodulin genes CALM1, CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3. Genomics (1993) 1.17
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb (1992) 1.17
PKC-beta is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol (2001) 1.16
The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med (1998) 1.15
Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem (1990) 1.14